Search alternatives:
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
4321
Basic characteristics included in the study.
Published 2025“…</p><p>Methods and analysis</p><p>We searched PubMed, Cochrane Library, Embase, and Web of Science for cohort studies published up to June 21, 2024, using relevant medical subject headings (MeSH) and keywords. …”
-
4322
Publication bias of the risk of all groups.
Published 2025“…</p><p>Methods and analysis</p><p>We searched PubMed, Cochrane Library, Embase, and Web of Science for cohort studies published up to June 21, 2024, using relevant medical subject headings (MeSH) and keywords. …”
-
4323
Study selection process.
Published 2025“…</p><p>Methods and analysis</p><p>We searched PubMed, Cochrane Library, Embase, and Web of Science for cohort studies published up to June 21, 2024, using relevant medical subject headings (MeSH) and keywords. …”
-
4324
The process of selecting participants.
Published 2024“…The primary endpoint was considered as OS and CSS. We conducted trend analysis of the incidence, OS and CSS rates of liver metastases in ovarian cancer. …”
-
4325
C-indexes for the nomograms.
Published 2024“…The primary endpoint was considered as OS and CSS. We conducted trend analysis of the incidence, OS and CSS rates of liver metastases in ovarian cancer. …”
-
4326
-
4327
-
4328
-
4329
-
4330
-
4331
Experimental design.
Published 2025“…The C and MNS group were gavaged with equal volume normal saline, the ML and MR group gavaged with lactulose at a dose of 10 mL/kg body weight and rifaximin at a dose of 50 mg/kg body weight respectively once a day for 8 weeks until the end of the experiment. …”
-
4332
-
4333
Patients outcome.
Published 2025“…Reliance on temporal-artery biopsy fell (17% vs 91%; p < 0.01), owing to a four-fold rise in diagnostic MRI use. Mean total medical costs decreased by €814 per patient (€3672 ± 2861 vs €4486 ± 3193), although this difference did not reach statistical significance (p = 0.23).…”
-
4334
Primers for qPCR.
Published 2025“…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
-
4335
Antibodies used for western blotting.
Published 2025“…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
-
4336
Target sequences of siRNAs.
Published 2025“…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
-
4337
Plasmids information.
Published 2025“…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
-
4338
Raw data.
Published 2025“…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
-
4339
-
4340
Baseline characteristics for pneumonia.
Published 2024“…For pneumonia, the ROC-AUCs were 50.1% [49.6%-50.6%], 69.2% [69.1%-69.2%] and 68.4% [68.0%-68.5%] for the linear models and 51.0% [49.7%-52.4%], 69.7% [.5%-70.8%] and 69.7% [68.6%-70.8%] for the deep learning SNP, clinical and combined models, respectively.…”